Skip to main navigation
Skip to search
Skip to main content
Oregon Health & Science University Home
Help & FAQ
Home
Profiles
Research units
Core Facilities
Publications
Search by expertise, name or affiliation
Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM)
PRISM investigators
Molecular and Medical Genetics
Research output
:
Contribution to journal
›
Article
›
peer-review
121
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM)'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
pegvaliase
100%
Phenylketonurias
59%
Phase III Clinical Trials
55%
Phenylalanine
45%
Anaphylaxis
14%
Anabaena variabilis
8%
Phenylalanine Ammonia-Lyase
8%
Therapeutics
7%
Hypersensitivity
7%
cinnamic acid
7%
National Institute of Allergy and Infectious Diseases (U.S.)
7%
Enzyme Therapy
6%
Injection Site Reaction
6%
Medical Genetics
6%
Food Hypersensitivity
5%
Safety
5%
Ammonia
5%
Arthralgia
4%
Erythema
4%
Genomics
4%
Immunoglobulin E
4%
Headache
3%
Maintenance
3%
Clinical Trials
3%
Guidelines
2%
Injections
2%
Population
1%
Chemical Compounds
Phenylalanine
46%
Dose
9%
Safety
7%
Trans-Cinnamic Acid
6%
Ammonia
6%
Reduction
3%
Titration
3%
Food
2%
Substitution Reaction
2%